Resistin Mouse ELISA

– Beier JI, Guo L, von Montfort C, Kaiser JP, Joshi-Barve S, Arteel GE. New role of resistin in lipopolysaccharide-induced liver damage in mice. J Pharmacol Exp Ther. 2008 Jun;325 (3):801-8

– Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, Devaney JM, Fishman C, Stamou S, Canos D, Zbinden S, Clavijo LC, Jang GJ, Andrews JA, Zhu J, Epstein SE. The potential role of resistin in atherogenesis. Atherosclerosis . Oct;182(2):241-8 (2005)

– Depke M, Fusch G, Domanska G, Geffers R, Volker U, Schuett C, Kiank C. Hypermetabolic syndrome as a consequence of repeated psychological stress in mice. Endocrinology. 2008 Jun;149 (6):2714-23

– Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Endocrinology . Sep;147(9):4517-24 (2006)

– Kurlawalla-Martinez Cm Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol . Mar;25(6):2498-510 (2005)